Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Newitt

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Radiology. Imaging Cancer|July 28, 2023
Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant TreatmentNatsuko Onishi, Teffany Joy Bareng, Jessica Gibbs, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response TrialDavid C Newitt, Ghoncheh Amouzandeh, Savannah C Partridge, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 8, 2016
Design of a breast phantom for quantitative MRIKathryn E Keenan, Lisa J Wilmes, Sheye O Aliu, et al.
Scientific Data|July 23, 2022
Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1Rhea Chitalia, Sarthak Pati, Megh Bhalerao, et al.
Tomography (Ann Arbor, Mich.)|March 22, 2022
Impact of Alternate <i>b</i>-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 TrialSavannah C Partridge, Jon Steingrimsson, David C Newitt, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2022
Long-Term Stability of Gradient Characteristics Warrants Model-Based Correction of Diffusion Weighting BiasYuxi Pang, Dariya I Malyarenko, Lisa J Wilmes, et al.
Journal of Breast Imaging|August 18, 2020
Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- PatientsVignesh A Arasu, Paul Kim, Wen Li, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer TrialNatsuko Onishi, Wen Li, Jessica Gibbs, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant TherapyAlex Anh-Tu Nguyen, Vignesh A Arasu, Fredrik Strand, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 27, 2019
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIALWen Li, David C Newitt, Lisa J Wilmes, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Radiology. Imaging Cancer|July 28, 2023
Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided Personalization of Breast Cancer Neoadjuvant TreatmentNatsuko Onishi, Teffany Joy Bareng, Jessica Gibbs, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response TrialDavid C Newitt, Ghoncheh Amouzandeh, Savannah C Partridge, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 8, 2016
Design of a breast phantom for quantitative MRIKathryn E Keenan, Lisa J Wilmes, Sheye O Aliu, et al.
Scientific Data|July 23, 2022
Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1Rhea Chitalia, Sarthak Pati, Megh Bhalerao, et al.
Tomography (Ann Arbor, Mich.)|March 22, 2022
Impact of Alternate <i>b</i>-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 TrialSavannah C Partridge, Jon Steingrimsson, David C Newitt, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2022
Long-Term Stability of Gradient Characteristics Warrants Model-Based Correction of Diffusion Weighting BiasYuxi Pang, Dariya I Malyarenko, Lisa J Wilmes, et al.
Journal of Breast Imaging|August 18, 2020
Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- PatientsVignesh A Arasu, Paul Kim, Wen Li, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer TrialNatsuko Onishi, Wen Li, Jessica Gibbs, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant TherapyAlex Anh-Tu Nguyen, Vignesh A Arasu, Fredrik Strand, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 27, 2019
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIALWen Li, David C Newitt, Lisa J Wilmes, et al.
Pageof 5